Comparative Evaluation of Urinary Biomarkers in Wilms Tumor Survivors and Children with Chronic Kidney Disease
International Journal of Molecular Sciences · 27.06.2025 · 26 (13) · 6238
DOI: 10.3390/ijms26136238 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.06.2025. Verfasst von Pawel Dubiela und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, 15-089 Bialystok, Poland. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Wilms Tumor, Biomarkers, Kidney Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Wilms tumor (WT), the most common pediatric renal malignancy, shares some clinical and pathological features with chronic kidney disease (CKD). Understanding biomarkers of kidney injury among CKD and WT patients is of high interest due to its potential implications for diagnosis, prognosis, and treatment strategies. This study enrolled twenty pediatric patients with WT (stage I–IV), forty with CKD (stage I–V), and twenty healthy volunteers. Urine samples were collected and six urine biomarkers (calbindin, clusterin, GST-π, IL-18, KIM-1, MCP-1) associated with kidney injury were assessed using the Bio-Plex Pro RBM Human Kidney Toxicity Assays kit (Bio-Plex Manager software 4.0). A comparative analysis of biomarker levels across the three groups revealed distinct patterns. Creatinine levels were notably elevated in CKD (1.32 ± 1.9) compared to WT (0.64 ± 0.26) and the control group. Tested biomarkers were calculated per milligram of urine creatinine, and all the differences among the groups were statistically significant. Pearson’s correlation coefficients showed strong interplay among CKD biomarkers. This study identified variations in biomarker patterns among WT and CKD patients. Understanding biomarker interactions may provide future diagnostic approaches for pediatric kidney conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, 15-089 Bialystok, Poland.
- Department of Pediatrics and Nephrology, Medical University of Bialystok, 15-089 Bialystok, Poland.
- Department of Pediatrics, Oncology and Hematology, Medical University of Bialystok, 15-089 Bialystok, Poland.
- Department of Physiology, Medical University of Bialystok, 15-089 Bialystok, Poland.
- Faculty of Mathematics, Informatics and Mechanics, University of Warsaw, 00-927 Warsaw, Poland.
ORCID-Profile: Pawel Dubiela, Katarzyna Taranta-Janusz, Katarzyna Konończuk, Adrian Chabowski, Eryk Latoch
Zitieren
APA
Dubiela, P., Taranta-Janusz, K., Konończuk, K., Konstantynowicz-Nowicka, K., Chabowski, A., Szymanska-Rozek, P., & Latoch, E. (2025). Comparative Evaluation of Urinary Biomarkers in Wilms Tumor Survivors and Children with Chronic Kidney Disease. International Journal of Molecular Sciences, 26(13), 6238. https://doi.org/10.3390/ijms26136238
Vancouver
Dubiela P, Taranta-Janusz K, Konończuk K, Konstantynowicz-Nowicka K, Chabowski A, Szymanska-Rozek P, et al. Comparative Evaluation of Urinary Biomarkers in Wilms Tumor Survivors and Children with Chronic Kidney Disease. International Journal of Molecular Sciences. 2025;26(13):6238. doi:10.3390/ijms26136238
BibTeX
@article{Dubiela2025,
author = {Dubiela, Pawel and Taranta-Janusz, Katarzyna and Konończuk, Katarzyna and Konstantynowicz-Nowicka, Karolina and Chabowski, Adrian and Szymanska-Rozek, Paulina and Latoch, Eryk},
title = {Comparative Evaluation of Urinary Biomarkers in Wilms Tumor Survivors and Children with Chronic Kidney Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {13},
pages = {6238},
doi = {10.3390/ijms26136238}
}
EUVIMED